Unintentional napping has been linked to a higher risk of developing possible or probable dementia, according to data from the National Health and Aging Trends Study published in the Journals of Gerontology: Series A.
A pooled analysis of six U.S. cohorts published in JAMA Neurology found that multiple vascular risk factors and a history of stroke were associated with an increased incidence of late-onset epilepsy.
Wide-reaching studies in Sweden and France, reported in Neurology, connected epilepsy with a heightened risk of young-onset dementia in younger populations.
An influential 2017 paper in Nature that proposed maternal gut bacteria as a driver of neurodevelopmental issues in mice now faces an editorial expression of concern over its methodology and conclusions.
The FDA has approved a once-daily autoinjector formulation of zilucoplan (marketed as Zilbrysq), a treatment for generalized myasthenia gravis, as announced by UCB.
With the prognostic value of Alzheimer’s biomarkers in asymptomatic individuals remaining uncertain, a neurologist advocates for preventive counseling over testing in JAMA Neurology.
According to a cohort study in JAMA Network Open, patients with intracerebral hemorrhage reached emergency departments faster than those with acute ischemic stroke but were less likely to achieve timely care benchmarks.
Researchers highlight the critical need for neurodata governance frameworks due to the low cost of neural recording technologies, as noted in The Transmitter.
Boston University researchers diagnosed NASCAR Hall of Famer Fred Lorenzen with stage 3 chronic traumatic encephalopathy (CTE), marking him as the first NASCAR driver to receive a confirmed posthumous diagnosis, according to the Concussion & CTE Foundation.
Also Read
- GSK’s Hibsago Secures FDA Approval for Potential Hepatitis B Functional Cure Treatment
- Roivant’s Lisraya Shows Promise in Uveitis as Cost Plus Drugs Expands Into Rare Disease Therapies
- Real-World Data Reinforces Efficacy of Long-Acting HIV Injectable Therapy
- California Secures $6M Settlement with Former 23andMe Over 2023 Genetic Data Breach Impacting Millions


